Medicare officials announced on Thursday that the health insurance program for older Americans will sharply limit coverage of a costly and controversial new Alzheimer’s drug.
* This article was originally published here
Medicare has decided to sharply limit coverage of Aduhelm, a new Alzheimer drug
